BDF Gestion’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Sell
18,034
-668
-4% -$683K 0.27% 98
2026
Q1
$17.2M Hold
18,702
2.3% 8
2025
Q4
$20.1M Sell
18,702
-1,247
-6% -$1.19M 2.46% 7
2025
Q3
$15.2M Sell
19,949
-4,149
-17% -$3.09M 1.8% 8
2025
Q2
$18.8M Sell
24,098
-2,626
-10% -$2.04M 2.1% 8
2025
Q1
$22.1M Hold
26,724
2.41% 6
2024
Q4
$20.6M Sell
26,724
-3,472
-11% -$2.87M 2.12% 8
2024
Q3
$5.85M Hold
30,196
0.63% 40
2024
Q2
$27.3M Buy
+30,196
New +$24.2M 2.63% 6

Other funds holding LLY

BDF Gestion's LLY Position: Q2 2026 in Review

BDF Gestion reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $683K and leaving 18,034 shares worth $2.04M. The position accounts for 0.27% of the portfolio, ranked #98.

BDF Gestion first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $27.3M in Q2 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BDF Gestion held 18,034 shares of Eli Lilly worth $2.04M as of Q2 2026.
  • BDF Gestion sold 668 Eli Lilly shares in Q2 2026, an estimated $683K.
  • Eli Lilly made up 0.27% of BDF Gestion's portfolio in Q2 2026, its #98 holding.
  • BDF Gestion first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • BDF Gestion's Eli Lilly position peaked at $27.3M in Q2 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.